🇺🇸 FDA

Intelligence Platform

Patents

Browse 14 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11596610

Compositions in support of health and mental accuity

HIGHER OPTIONS GLOBAL, INC. · Granted Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265411

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117937

Highly branched alpha-D-glucans

Phytoption LLC · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9907855

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9616136

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9289513

Targeted cytokine for treatment of musculoskeletal diseases

OPTION PHARMACEUTICALS, LLC · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9226971

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685932

Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

OPTION PHARMACEUTICALS, LLC · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6770283

DNA expression systems based on alphaviruses

Bioption AB · Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6692750

Alphavirus expression vector

Bioption AB · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566093

Alphavirus cDNA vectors

Bioption AB · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6224879

Alphavirus expression vector

Bioption AB · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190666

DNA expression systems based on alphaviruses

Bioption · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6013122

Tattoo inks

Option Technologies Corp. · Granted Tue Jan 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired